Cardiac events and economic burden among patients with hypertension and treated insomnia in the USA.
MetadataShow full item record
AbstractBackground: Cardiovascular (CV) event risk, healthcare resource utilization (HCRU) and costs have not been elucidated among hypertension patients with treated insomnia (H + TI). Materials & methods: Adult patients with H + TI were identified in IBM MarketScan databases. H + TI patients were matched 1:1 on age and sex to controls with hypertension but without sleep disorders. Multivariable models were used to estimate associations between treated insomnia and CV event risk, HCRU and costs. Results: In total, 81,502 H + TI patients (mean age = 62 years, 53% female) were matched. Relative to controls, H + TI patients were 2.4 times as likely to have CV events. H + TI patients incurred higher costs per patient per month (US$2343 vs US$1013). Conclusion: Treated insomnia was associated with higher costs and HRCU in hypertension patients.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19370
- Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study.
- Authors: Amari DT, Juday TR, Frech FH, Wang W, Gor D, Atkins N Jr, Wickwire EM
- Issue date: 2022 Mar
- Incremental health care resource use and costs among adult patients with depression and treated for insomnia with zolpidem, trazodone, or benzodiazepines.
- Authors: Wickwire EM, Amari DT, Juday TR, Frech F, Gor D, Malhotra M
- Issue date: 2022 May
- Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines.
- Authors: Amari DT, Juday T, Frech FH, Wang W, Wu Z, Atkins N Jr, Wickwire EM
- Issue date: 2022 Jun 4
- Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
- Authors: Qureshi ZP, Thiel E, Nelson J, Khandker R
- Issue date: 2021
- Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant.
- Authors: Kale HP, Qureshi ZP, Shah R, Khandker R, Botteman M, Meng W, Benca R
- Issue date: 2021 Oct